Continuous Administration of Subcutaneous Levodopa/Carbidopa (ND0612) Demonstrated Comparable Levodopa Pharmacokinetics to Levodopa/Carbidopa Intestinal Gel (LCIG)

被引：0
|
作者：
Adar, Liat [1 ]
Minei, Tamar Rachmilewitz [1 ]
Cohen, Yael [1 ]
Oren, Sheila [1 ]
机构：
[1] NeuroDerm Ltd, Rehovot, Israel
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S4.003
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Baseline characteristics of the population enrolled to a randomized clinical study of subcutaneous levodopa/carbidopa (ND0612) infusion in patients with advanced PD
    Olanow, W.
    Ellenbogen, A.
    Djaldetti, R.
    Minei, T. Rachmilewitz
    Cohen, Y.
    Oren, S.
    Kieburtz, K.
    MOVEMENT DISORDERS, 2017, 32
  • [42] Dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion: Management inclinical practice
    Melgari, Jean-Marc
    Salomone, Gaetano
    di Biase, Lazzaro
    Marano, Massimo
    Scrascia, Federica
    Di Lazzaro, Vincenzo
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (03) : 327 - 328
  • [43] The effect of tolcapone on levodopa pharmacokinetics is independent of levodopa/carbidopa formulation
    Jorga, K
    Fotteler, B
    Sedek, G
    Nielsen, T
    Aitken, J
    JOURNAL OF NEUROLOGY, 1998, 245 (04) : 223 - 230
  • [44] COST EFFECTIVENESS OF LEVODOPA/CARBIDOPA INTESTINAL GEL IN IRELAND
    Baj, R.
    Egan, K. M.
    McCarthy, J.
    VALUE IN HEALTH, 2015, 18 (03) : S283 - S283
  • [45] Vitamins and Infusion of Levodopa-Carbidopa Intestinal Gel
    Taher, Jennifer
    Naranian, Taline
    Poon, Yu-Yan
    Merola, Aristide
    Mestre, Tiago
    Suchowersky, Oksana
    Kulasingam, Vathany
    Fasano, Alfonso
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2022, 49 (01) : 19 - 28
  • [46] Continuous subcutaneous carbidopa improves levodopa pharmacokinetics in Parkinson's disease patients
    Caraco, Y.
    Giladi, N.
    Oren, S.
    LeWitt, P. A.
    MOVEMENT DISORDERS, 2012, 27 : S111 - S111
  • [47] Experiences with levodopa/carbidopa intestinal gel (LCIG) therapy in patients under and over 65 years
    Takats, A.
    Nagy, H.
    Toth, A.
    MOVEMENT DISORDERS, 2014, 29 : S148 - S148
  • [48] Levodopa carbidopa intestinal gel (LCIG) infusion during pregnancy and delivery: First documented case
    Zlotnik, Yair
    Giladi, Nir
    Hilel, Ariela
    Shapira, Yami
    Goldstein, Sarah
    Gurevich, Tanya
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (11) : 1317 - 1318
  • [49] Jejunal Infusion of Levodopa–Carbidopa Intestinal Gel Versus Oral Administration of Levodopa–Carbidopa Tablets in Japanese Subjects with Advanced Parkinson’s Disease: Pharmacokinetics and Pilot Efficacy and Safety
    Ahmed A. Othman
    Krai Chatamra
    Mohamed-Eslam F. Mohamed
    Sandeep Dutta
    Janet Benesh
    Masayoshi Yanagawa
    Masahiro Nagai
    Clinical Pharmacokinetics, 2015, 54 : 975 - 984
  • [50] Foslevodopa/foscarbidopa subcutaneous infusion maintains equivalent levodopa exposure to Levodopa-Carbidopa Intestinal Gel delivered to the jejunum
    Rosebraugh, Matthew
    Stodtmann, Sven
    Liu, Wei
    Facheris, Maurizio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 331 - 331
12345